<DOC>
	<DOCNO>NCT02111200</DOCNO>
	<brief_summary>The investigator study compare effectively sodium phenylbutyrate , sodium benzoate , combination two , help excrete nitrogen healthy volunteer . Subject participation require three , separate , four-day study period least one week apart . During one study period ( also call treatment arm ) , subject take sodium phenylbutyrate ; another take sodium benzoate ; another take combination two medication . We expect find phenylbutyrate effective remove nitrogen benzoate combination two .</brief_summary>
	<brief_title>Comparative Efficacy Phenylbutyrate ( PBA ) vs. Benzoate Urea Cycle Disorders</brief_title>
	<detailed_description />
	<mesh_term>Urea Cycle Disorders , Inborn</mesh_term>
	<mesh_term>4-phenylbutyric acid</mesh_term>
	<mesh_term>Sodium Benzoate</mesh_term>
	<criteria>Healthy volunteer Subjects ( ) history frequent dietary protein intolerance , ( b ) history chronic acute liver disease may result altered hepatic synthetic capacity ( e.g. , hepatitis ) , ( c ) acute chronic disease medication opinion clinical investigator interfere measurement ( e.g. , drug may hepatotoxicity potential side effect ) , ( ) physical disability interfere ability either conform dietary regime undergo isotopic infusion , ( e ) pregnancy recent ( &lt; 6 month ) /current lactation , ( f ) intercurrent evidence significant hyperammonemia ( 100 Âµmol/L ) , ( g ) clinical abnormality Grade 3 great accord Common Terminology Criteria Adverse Events v.4.0 ( CTCAE ) , ( h ) condition ( ) cover CTCAE , ( ) severe lifethreatening toxicity screening , exclude study . Subjects take ammonia scavenger medication enrol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>UCD</keyword>
</DOC>